Fundology

BTEE holdings

As of , BTEE (iShares NASDAQ US Biotechnology UCITS ETF Dist, ISIN IE00BDZVHG35) has 244 holdings on our record. The fund reports 250 positions in all. Weights are shares of the whole fund.

BTEE: price, returns and charges

Holdings
244
250 reported in all
Ten largest
48.5%
of the whole fund
Effective number of holdings
29
As concentrated as this many equal-sized holdings (how it is worked out)
Largest holding
9.0%
Gilead Sciences

Map of the largest holdings

The 10 largest holdings of BTEE, together 48.5% of the fund. Each tile’s area is its share of the whole fund; the colour is its sector. Signed-in members can read every holding in the Holdings tab.

Gilead Sciences (GILD): 8.96% of the fund · Health CareGilead Sciences9.0%Amgen (AMGN): 8.40% of the fund · Health CareAmgen8.4%Vertex Pharmaceuticals (VRTX): 7.88% of the fund · Health CareVertex Pharmaceuticals7.9%Moderna (MRNA): 6.52% of the fund · Health CareModerna6.5%Regeneron Pharmaceuticals (REGN): 5.88% of the fund · Health CareRegeneron Pharmaceuticals5.9%Revolution Medicines (RVMD): 2.65% of the fund · Health CareRevolution Med…2.6%Biogen (BIIB): 2.36% of the fund · Health CareBiogen2.4%Illumina (ILMN): 2.07% of the fund · Health CareILMN2.1%Royalty Pharma · Class A (RPRX): 1.93% of the fund · Health CareRPRX1.9%Roivant Sciences (ROIV): 1.81% of the fund · Health CareROIV1.8%
  • Health Care 48.5%

Weights of the whole fund, as of 06/11/2026. The same holdings as a list

As of

More:BTEE: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured

Holdings and weights are as published on 06/11/2026 and change as the fund trades. This is information, not advice.